国家: 台湾
语言: 中文
来源: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
雄恆行股份有限公司 台北巿民權東路三段58號八樓 (03413602)
試劑
試劑體外用
由醫師或檢驗師使用
HYLAND DIVISION OF TRAVENOL LAB. INC. 3300 HYLAND AVENUE COSTA MESE. CALIFORNIA 92626 US
註銷日期: 2006/08/23; 註銷理由: 有效期限已屆; 有效日期: 1985/12/08; 英文品名: ANTI-RH SERUM (RABBIT)
已註銷
1972-12-08
1 SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET 2 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 3 1. NAME OF THE MEDICINAL PRODUCT NORMOSANG 25 mg/ml, concentrate for solution for infusion. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Human hemin ........................................................................................................................................ 25 mg/ml. One ampoule of 10 ml contains 250 mg of human hemin. After dilution of one 10 ml ampoule in 100 ml of 0.9% Na Cl solution, the diluted solution contains 2273 micrograms per ml of human hemin. Excipient with known effect: ethanol 96% (1 g / 10 ml) (see section 4.4). For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Concentrate for solution for infusion. NORMOSANG is a dark coloured concentrate for solution for infusion. 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS Treatment of acute attacks of hepatic porphyria (acute intermittent porphyria, porphyria variegata, hereditary coproporphyria). 4.2. POSOLOGY AND METHOD OF ADMINISTRATION Posology The recommended daily dose is 3 mg/kg once daily for four days, diluted in 100 ml of 0.9% sodium chloride in a glass bottle and infused intravenously over at least 30 minutes into a large antebrachial or central vein using an inline filter. The dose should not exceed 250 mg (1 ampoule) per day. Exceptionally, the course of the treatment may be repeated under strict biochemical surveillance if there is inadequate response after the first course of treatment. _Elderly patients_ No dose adjustment is required. _Children and adolescents _ Attacks of porphyria are rare in children but limited experience in tyrosinaemia suggests that it is safe to use a dose of not more than 3 mg/kg daily for 4 days, administered with the same precautions as for adults. Method of administration 4 The infusions should be administered in a large antebrachial or central vein over a period of at least 30 minutes. After the infusion, the vein should be rinsed with 100 ml o 阅读完整的文件